Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Country / region: Norway Clear all

116 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20025
20033
20048
20056
20065
20076
200810
200911
20109
20116
20124
20137
20144
20154
20162
20176
20181
20193
20202
20211
20222
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed93
Terminated13
Unknown status6
Recruiting2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S27
AstraZeneca13
Boehringer Ingelheim12
Norwegian University of Science and Technology10
Novartis Pharmaceuticals5
GlaxoSmithKline4
Oslo University Hospital4
Sanofi4
University of Oslo3
University of Tromso3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2116
Diabetes Mellitus41
Cardiovascular Diseases7
Hypertension7
Obesity7
Insulin Resistance5
Coronary Artery Disease4
Dyslipidemias4
Glucose Intolerance4
Metabolic Syndrome4

Trials

Showing 51 to 75 of 116. Each trial links to its page on Pharma Observatory.

16 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.